San Francisco is known for the Gold Rush, so it’s a particularly fitting place to collect a gold nugget. And so at the 2015 ACR/ARHP Annual Meeting in the Golden Gate City in November, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and…
James K. Smith, MD, believes in thinking several moves ahead. Consider your opponent. Gauge your strategy. Be aggressive when you need to be. Those are key aspects of his philosophy in rheumatology—and chess. Initiation Dr. Smith’s love of chess started after he had started his family. “I first got involved in the game through my…
Two months into the transition, the ICD-10 code set is still not exactly the most enticing reading material. But there is still so much to learn and apply, that it is necessary for physicians, coders and billers to stay abreast of the coding and billing guidelines. Although all of the guidelines and conventions may be…
Patient education has always been at the core of the nursing profession. Nurses pride themselves on being great teachers and patient advocates. When self-injectable biologics were first introduced to the market, one of the main goals was to make patients independent and put them in the driver’s seat of their own care. Yet without a…
The Rheumatology Research Foundation has infused more than $130 million into rheumatology research, education and training since it was established in 1985. The Foundation’s efforts have been greatly enhanced by the support of Corporate Roundtable (CRT) members. The CRT is a dynamic partnership between the Foundation and members of the pharmaceutical industry committed to furthering…
Meet the Foundation’s incoming president, Eric L. Matteson, MD, MPH. Dr. Matteson trained in rheumatology at the University of Michigan and Mayo Graduate School of Medicine, Mayo Clinic College of Medicine. He later earned his Master of Public Health in epidemiology at the University of North Carolina, Chapel Hill. Dr. Matteson currently works as the…
As usual, your items in The Rheumatologist remain timely. In the case of attracting medical students into rheumatology, your piece is also timeless. For many years now, I have recommended to various officers of the ACR that we obtain a list of students and their home addresses when they are admitted to medical school. At…
I want to thank you for writing the article, “Attracting More Medical Students to Rheumatology” for The Rheumatologist (online, October 2015). I am a senior at Georgetown University now, and I have recently applied to medical school. I have considered pursuing a career in rheumatology, and your article has inspired me to stay on that…
After its December meeting, the ACR Government Affairs Committee has determined the federal and state issues the College will focus its advocacy efforts on in 2016. These issues include ensuring implementation of the Medicare Access & CHIP Reauthorization Act of 2015 protects rheumatologists, creating an arthritis research program at the Department of Defense and more…
LONDON (Reuters)—The number of new drugs approved in the U.S. this year has already topped last year’s 18-year high, yet large pharmaceutical companies are still struggling to get a decent return on their research dollars. In fact, returns on research and development (R&D) spending by the world’s top drug makers have fallen to just 4.2%,…